De novo proteomic sequencing of a monoclonal antibody raised against OX40 ligand

peer-reviewed · Analytical Biochemistry · 2006

peer-reviewed · Analytical Biochemistry · 2006. Victoria Pham et al. De novo sequencing of a full-length monoclonal antibody raised against OX40 ligand is described. Using a…
Date 2006-05-01
Type peer-reviewed
Venue Analytical Biochemistry
Publisher Elsevier BV
Contribution downstream-application
DOI 10.1016/j.ab.2006.02.001
Citations (OpenAlex) 30

Abstract

De novo sequencing of a full-length monoclonal antibody raised against OX40 ligand is described. Using a combination of overlapping complementary proteolytic and chemical digestions, with analysis by mass spectrometry and Edman degradation, both the heavy and light chains were fully sequenced. Particular attention was paid to those modifications that could be susceptible to degradation in the complementarity determining region and Fc region. An overview of the protocol is described, and suggestions for improvements to aid in such sequencing projects in the future are discussed.

Authors

  1. Victoria Pham
  2. William J. Henzel
  3. David Arnott · Genentech, Inc.
  4. Sarah Hymowitz
  5. Wendy N. Sandoval
  6. Bao-Tran Truong
  7. Henry Lowman
  8. Jennie R. Lill · Genentech, Inc.

Methods and tools

  • Anti-OX40L mAb de novo sequencing: Full-length de novo sequencing of a monoclonal antibody raised against OX40 ligand, from overlapping proteolytic and chemical digests read by mass spectrometry and cross-checked by Edman degradation.

Cited by (7)

Seen in the charts

Back to the full map

Back to top